Materials in this website may contain information that includes or is based upon forward-looking statements. These forward-looking statements are based on the current beliefs, expectations and assumptions of our management with respect to future events and are subject to a number of significant risks and uncertainties. It is important to note that Cerner's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words “should,” “could,” “will be,” “intended,” “continue,” “believe,” “may,” “expects,” “estimate,” “hope,” “anticipate,” “goal,” “forecast”, “guidance”, “position”, “projected”, “outlook”, “opportunity”, “future”, “target”, “potential” or the negative of these words, variations thereof or and similar expressions are intended to identify such forward-looking statements. For example, our forward-looking statements may include statements regarding projections of future revenues or earnings, operating margins, operating and capital expenses, bookings, new solution, services and offering development, and capital allocation plans; cost optimization and operational improvement initiatives; future business outlook, including new markets or prospects for the Company’s solutions and services; and the expected benefits of certain of our acquisitions, divestitures or other investments or collaborations. Factors that could cause or contribute to such differences include, but are not limited to: the extent to which the COVID-19 pandemic and measures taken in response thereto could adversely affect our financial condition, future bookings and results of operations; the possibility of interruption at our data centers or client support facilities, or those of third parties with whom we have contracted (such as public cloud providers), that could expose us to significant costs and reputational harm; the possibility of increased expenses, exposure to legal claims and regulatory actions and reputational harm associated with a cyberattack or other breach in our IT security or the IT security of third parties on which we rely; potential claims for system errors and warranties or significant costs and reputational harm related to product and service-related liabilities; our proprietary technology may be subject to claims for infringement or misappropriation of intellectual property rights of others, or may be infringed or misappropriated by others, or subject to claims related to open source licenses; material adverse resolution of legal proceedings or other claims or reputational harm stemming from negative publicity related to such claims or legal proceedings; risks associated with our global operations, including without limitation greater difficulty in collecting accounts receivable; significant competition and our ability to anticipate or respond quickly to market changes, changing technologies and evolving pricing and deployment methods and to bring competitive new solutions, devices, features and services to market in a timely fashion; risks inherent with business acquisitions, strategic investments, collaborations and the failure to achieve projected synergies, or divestitures; managing growth in the new markets in which we offer solutions, health care devices or services; long sales cycles for our solutions and services; risks related to our dependence on strategic relationships and third party suppliers, including any impact to such supplier’s business resulting from the COVID-19 pandemic; risks associated with the loss or recruitment and retention of key personnel or the failure to successfully develop and execute succession planning to assure transitions of key associates and their knowledge, relationships and expertise; inability to achieve expected operating efficiencies and sustain or improve operating expense reductions or business disruptions or adverse tax consequences associated with restructuring, realignment and costs reduction activities; changing political, economic and regulatory influences, which could impact the purchasing practices and operations of our clients and increase costs to deliver compliant solutions and services; non-compliance with laws, regulations or certain industry initiatives or failure to deliver solutions or services that enable our clients to comply with laws or regulations applicable to their businesses; risks inherent in contracting with government clients, including without limitation, complying with strict compliance and disclosure obligations, navigating complex procurement rules and processes, and defending against bid protests; volatility and disruption resulting from global economic or market conditions, including the impact from the COVID-19 pandemic; risks associated with our outstanding and future indebtedness, such as compliance with restrictive covenants, which may limit our flexibility to operate our business; risk that our capital allocation strategy will not be fully implemented or enhance long-term shareholder value; changes in tax laws, regulations or guidance that could adversely affect our tax position and/or challenges to our tax positions in the U.S. and non-U.S. countries; the potential for losses resulting from asset impairment charges; potential variations in our sales forecasts compared to actual sales; risks that our revenue growth may be lower than anticipated and/or that the mix of revenue shifts to low margin revenue; variations in our quarterly operating results; volatility in the trading price of our common stock and the timing and volume of market activity; risks associated with fluctuations in foreign currency exchange rates; and our directors’ authority to issue preferred stock and the anti-takeover provisions in our corporate governance documents. Additional discussion of these and other risks, uncertainties and factors affecting Cerner’s business that could cause actual results to differ materially from those in the forward-looking statements may be found under the heading “Risk Factors” in Item 1A of our most recent Annual Report on Form 10-K, and other filings with the SEC. Our forward-looking statements speak only as of the date they are made. Except as required by law, we undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes in our business, results of operations or financial condition over time.
For 40 years, we’ve worked at the intersection of healthcare and information technology to connect people and systems around the world. It’s our mission to relentlessly seek breakthrough innovation that will shape healthcare of tomorrow.
Read the latest from thought leaders at the intersection of health and care.
Be a part of something that matters. Something that affects every single person, every single day — people’s health and the care they receive.
When our clients move the meter in healthcare – increasing quality of care, reducing waste, and lowering costs – we celebrate their efforts and share the wisdom gained by their success.
Cerner executives and Board of Directors provide leadership for one of the leading companies in healthcare information technology.
We are devoted to improving the quality of life for everyone we serve. We seek to enhance communities through the development of healthy and educated individuals.
We applaud the accomplishments of our clients and associates.
We strive to align our supplier relationships to extend, enable, and maximize the benefits our clients derive from Cerner solutions.
The Board of Directors at Cerner has the responsibility to oversee management for the benefit of its owners, the shareholders. Corporate governance is one of the most important ways the Board carries out those oversight duties.
Cerner is transforming the healthcare of tomorrow through responsible innovation. We respect and encourage the perspectives of every person, value our diversity, act with integrity and diligently deliver on our commitments.
Diversity, equity and inclusion is core to our mission. Our associates make up diverse teams from across the globe, bringing unique perspectives to their work to deliver smart solutions that improve the future of healthcare.
Senior Vice President, Investor Relations